Showing results (2251-2260 of 2,678) with videos related to

Sort By:
Pageof 268
Applied Optics|December 15, 2010
Characterization of a submillimeter high-angular-resolution camera with a monolithic silicon bolometer array for the Caltech Submillimeter ObservatoryN Wang, T R Hunter, D J Benford, et al.
Journal of Neural Transmission. Supplementum|August 30, 2003
Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's diseaseR L Watts, C D Raiser, N P Stover, et al.
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Plos One|November 3, 2012
High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencingNancy B Y Tsui, Peiyong Jiang, Katherine C K Chow, et al.
The Laryngoscope|November 3, 2022
Characteristics of Orbital Injuries Associated with Maxillofacial TraumaJames F Eng, Sami Younes, Brielle R Crovetti, et al.
Anesthesiology|April 1, 1994
A clinical grading scale to predict malignant hyperthermia susceptibilityM G Larach, A R Localio, G C Allen, et al.
Pediatric Rheumatology Online Journal|December 26, 2014
Independent confirmation of juvenile idiopathic arthritis genetic risk loci previously identified by immunochip array analysisRachel C Chiaroni-Clarke, Jane E Munro, Raul A Chavez, et al.
Scientific Reports|December 3, 2017
Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcomeKathleen J Till, John C Allen, Fatima Talab, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazolesJ T Strupczewski, R C Allen, B A Gardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group StudyStewart Goldman, Eric Bouffet, Paul G Fisher, et al.
Pageof 268